Current News in Medicine
Dr. House
Dr. House
Saturday, May 16, 2015
Three Diabetes Drugs Linked to Ketoacidosis, FDA Warns
FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment